TABLE 2.
Group | Immunizationa |
Challenge |
||||
---|---|---|---|---|---|---|
Mortality (%) | Isolation of challenge strainb |
|||||
Prime | Booster | No. of infected livers/no. of livers tested | No. of infected spleens/no. of spleens tested | |||
A | JOL911 | None | 10 | 80 | 2/2 | 2/2 |
B | JOL911 | JOL911 | 10 | 60 | 1/4 | 1/4 |
C | JOL906 | None | 10 | 40 | 4/6 | 4/6 |
D | JOL906 | JOL906 | 10 | 30 | 3/7 | 3/7 |
E | 4 parts JOL911 and 1 part JOL906 | JOL911 | 10 | 0 | 0/10 | 0/10 |
F | 4 parts JOL911 and 1 part JOL906 | 4 parts JOL911 and 1 part JOL906 | 10 | 30 | 2/7 | 2/7 |
G | PBS | PBS | 10 | 100 | ND | ND |
JOL911 is a vaccine strain, and JOL906 is an LTB protein-secreting strain. The total number of inoculated bacterial cells per dose for all animals was 2 × 109 CFU in a volume of 20 μl.
ND, not detected.